COMMERCIAL CHANNEL STRATEGY
How a young biotech company with only a handful of employees was fully contracted and on schedule to implement in advance of launch.
A young biotech company is preparing to launch a new product into a rare neurological disease state.
Initially, the organization included only two individuals who were new to the pharmaceutical industry.
Archbow was hired to help determine the channel strategy and best vendors to support full commercialization.
Archbow took a deep dive with the client to better understand philosophy and develop approach:
Reviewed disease state thoroughly
Conducted internal stakeholder interviews
Pre-qualified potential vendors and managed all NDAs
Created customized RFP for all channels
Issued and managed RFPs to 23 pre-qualified potential vendors
Scored and analyzed proposal responses
Coordinated and conducted finalist site visits with clients
Vendors selected for EAP, 3PL, SP, and HUB
Contracts negotiated to client’s benefit
Channel strategy fully contracted and on schedule to implement in advance of launch